Keyphrases
Pelvis
100%
18F-FDG PET-CT
100%
Solid Tumors
100%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
100%
PET-MRI
100%
Measurement Repeatability
100%
Positron Emission Tomography-computed Tomography (PET-CT)
38%
Repeatability
38%
SUVmax
15%
Apparent Diffusion Coefficient
15%
PET Image Reconstruction
15%
Within-subject Coefficient of Variation
15%
Between-session
15%
Treatment Monitoring
7%
PET Imaging
7%
Quantitative PET
7%
MRI Scan
7%
18F-fluorodeoxyglucose (18F-FDG)
7%
Attenuation Correction
7%
Lean Body Mass
7%
CT-MRI
7%
Imaging Protocol
7%
Diffusion-weighted Imaging
7%
Anatomic
7%
Therapeutic Efficacy
7%
Efficacy Assessment
7%
Oncological Treatment
7%
Quantitative MRI
7%
Oncologic Therapy
7%
Within-subject Variability
7%
SUVpeak
7%
Repeat Imaging
7%
Pelvic Malignancy
7%
Pelvic Cancer
7%
MRI Measurements
7%
SULpeak
7%
Testretest
7%
Uptake Time
7%
Dixon Imaging
7%
List-mode Acquisition
7%
Frame Duration
7%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Pelvis
100%
Fluorodeoxyglucose F 18
100%
Solid Malignant Neoplasm
100%
Positron Emission Tomography - Magnetic Resonance Imaging
100%
Measurement Repeatability
100%
Positron Emission Tomography
30%
Magnetic Resonance Imaging
15%
Treatment Response
7%
Positron Emission Tomography
7%
Cancer
7%
Prospective Study
7%
Combination Therapy
7%
Cohort Analysis
7%
Lean Body Weight
7%
Diffusion MRI
7%
Efficacy Assessment
7%
Pelvis Cancer
7%